Global Medical REIT (GMRE) Form 144: 130,000 Shares Proposed Sale

Rhea-AI Filing Summary

Global Medical REIT Inc. (GMRE) Form 144: This notice reports a proposed sale of 130,000 common shares, with an aggregate market value of $878,000.00. The shares were acquired on 08/07/2025 as a stock award from the issuer and paid as compensation. The filer lists Fidelity Brokerage Services LLC (245 Summer Street, Boston MA) as the broker and identifies an approximate sale date of 08/15/2025 on the NYSE. The issuer's reported number of shares outstanding is 66,878,728. The filing states there were no securities sold in the past three months by the person for whose account the securities will be sold. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Full disclosure of transaction details including broker, acquisition date, nature of acquisition, and approximate sale date
• No securities sold in prior three months by the same person, clarifying aggregation under Rule 144

Negative

• Insider intends to sell 130,000 shares, representing a proposed disposition of issuer stock valued at $878,000
• Shares were acquired and are being sold shortly thereafter (acquired 08/07/2025; approximate sale 08/15/2025)

Insights

Securities Analyst

TL;DR: Insider plans to sell 130,000 shares (~$878k) acquired as compensation; disclosure is routine and provides liquidity detail.

The Form 144 shows a proposed sale of 130,000 common shares acquired 08/07/2025 as a stock award and identified as compensation. The aggregate market value is listed at $878,000 and the approximate sale date is 08/15/2025 through Fidelity on the NYSE. The filing notes no sales in the prior three months, which clarifies the timing and aggregation of transactions required under Rule 144. From an investor-information perspective, this is a standard Section 16/Rule 144 disclosure that documents an insider monetizing equity compensation; it does not by itself indicate operational or financial changes at the issuer.

Corporate Governance Expert

TL;DR: The filing is a compliance disclosure for an insider sale of award shares; it affirms standard representations about material nonpublic information.

The form indicates the securities were received as a stock award from the issuer and will be sold roughly one week later. The signer affirms they are unaware of undisclosed material adverse information and references the trading-plan/Rule 10b5-1 statement language. The document contains the required broker and share-outstanding details. Governance implications are limited to ordinary insider monetization and compliance transparency; no departures, litigation, or other governance events are disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	130000	878000.00	66878728	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/07/2025	Stock Award	Issuer			130000	08/07/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does GMRE Form 144 report?

The notice reports a proposed sale of 130,000 common shares of Global Medical REIT Inc. (GMRE) with aggregate market value $878,000.00.

When were the shares acquired and how were they acquired?

The shares were acquired on 08/07/2025 as a stock award from the issuer and payment is listed as compensation.

Which broker and exchange are listed for the sale?

The broker is Fidelity Brokerage Services LLC (245 Summer Street, Boston MA) and the approximate sale date is 08/15/2025 on the NYSE.

How many shares of GMRE are outstanding per the filing?

The filing lists 66,878,728 shares outstanding.

Does the filing report any sales in the past three months by the seller?

No. The filing states Nothing to Report for securities sold during the past three months.